deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT00513526

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men

Sponsor: AIDS Malignancy Consortium

Conditions Infection Precancerous Condition
Interventions Gardasil
Updated 11 times since 2017 Last updated: Oct 27, 2023 Started: Nov 30, 2007 Primary completion: May 31, 2010 Completion: Oct 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Infection and Precancerous Condition, this trial is completed. The trial is conducted by AIDS Malignancy Consortium and has accumulated 11 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshotCompleted~Jun 2019 – ~Jan 2021 · 19 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Dec 2023 · 11 months · monthly snapshotCompleted~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Dec 2023 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jan 2023 — Dec 2023 [monthly]

    Completed PHASE2

▶ Show 6 earlier versions

  1. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  2. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2

  3. Jun 2019 — Jan 2021 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jun 2019 [monthly]

    Completed PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

  6. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AIDS Malignancy Consortium
  • National Cancer Institute (NCI)
  • The Emmes Company, LLC
Data source: AIDS Malignancy Consortium

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations